Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 100 Key Players companies in Orally disintegrating tablet
by Most Patent Filings in the China in 2022

The Orally disintegrating tablet top 100 is Discovery PatSnap’ annual ranking of the top 100 Most Patent Filings Orally disintegrating tablet Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken. Common among all age groups, dysphagia is observed in about 35% of the general population, as well as up to 60% of the elderly institutionalized population and 18-22% of all patients in long-term care facilities ODTs may have a faster onset of effect than tablets or capsules, and have the convenience of a tablet that can be taken without water. During the last decade, ODTs have become available in a variety of therapeutic markets, both OTC and by prescription.
#
Company Name
Region
Tech Topics
Total
1
Patent: 30
2
Patent: 22
3
Patent: 14
4
Glucophage,Metformin,Drug,
...[+2]
Patent: 13
5
Patent: 9
6
Patent: 8
7
Patent: 8
8
Nanchang Hongyi Technology Co., Ltd.
Patent: 7
9
Patent: 6
10
Patent: 6
11
Patent: 5
12
Patent: 5
13
Patent: 5
14
Patent: 5
15
Pill,Gastrointestinal agent,Drug,
...[+2]
Patent: 4
16
Patent: 4
17
Medicine,Health care
Patent: 4
18
Health care,Research system,International health,
...[+2]
Patent: 4
19
Patent: 4
20
Patent: 4
21
Patent: 4
22
Patent: 4
23
Patent: 4
24
Patent: 4
25
Excipient,Medicine,Health care,
...[+2]
Patent: 3
26
Patent: 3
27
Patent: 3
28
Patent: 3
29
Patent: 3
30
Patent: 3
31
Patent: 2
32
Patent: 2
33
Toothpaste,Yunnan Baiyao,Fast-moving consumer goods,
...[+2]
Patent: 2
34
Patent: 2
35
Medical equipment,Total asset,Drug,
...[+2]
Patent: 2
36
Patent: 2
37
Patent: 2
38
Patent: 2
39
Patent: 2
40
Patent: 2
41
Patent: 2
42
Beijing Hua Xi Lianhe Tech & Development Ltd.
Patent: 2
43
Patent: 2
44
Cardiovascular agent,Metoprolol,Valsartan,
...[+2]
Patent: 2
45
Patent: 2
46
Patent: 2
47
Patent: 2
48
Patent: 2
49
Patent: 2
50
Patent: 2
51
Patent: 2
52
Patent: 2
53
Patent: 2
54
Patent: 2
55
Patent: 2
56
Chongqing Liyang Pharmaceutical Development Co., Ltd.
Patent: 2
57
Patent: 2
58
Zhejiang Poly Pharm. Co., Ltd.
Patent: 2
59
Patent: 2
60
Patent: 2
61
Patent: 1
62
Patent: 1
63
Patent: 1
64
Patent: 1
65
Patent: 1
66
Drug,Health care,Emergency contraception,
...[+2]
Patent: 1
67
Patent: 1
68
Patent: 1
69
Patent: 1
70
Patent: 1
71
Patent: 1
72
Patent: 1
73
Patent: 1
74
Patent: 1
75
Health care
Patent: 1
76
Patent: 1
77
Patent: 1
78
Regenex Corp.
Patent: 1
79
Patent: 1
80
Patent: 1
81
Patent: 1
82
Patent: 1
83
Patent: 1
84
Patent: 1
85
Drug development,Medicine,Health care,
...[+2]
Patent: 1
86
Patent: 1
87
Patent: 1
88
Patent: 1
89
Patent: 1
90
Patent: 1
91
Patent: 1
92
Patent: 1
93
Patent: 1
94
Patent: 1
95
Patent: 1
96
Patent: 1
97
Shandong Hongjitang Pharmaceutical Group Co. Ltd
Patent: 1
98
Patent: 1
99
Patent: 1
100
Patent: 1
Page generation time: May 13 2025